Diabetes, Vol 40, Issue 4 436-443, Copyright © 1991 by American Diabetes Association

ARTICLES

Degradation of intraendosomal insulin by insulin-degrading enzyme without acidification

FG Hamel, MJ Mahoney and WC Duckworth
Department of Internal Medicine, University of Nebraska Medical Center, Omaha 68198-3020.

The nature of insulin degradation within endosomes was studied in vitro. Radiolabeled insulin was perfused into rat liver via the portal vein, and insulin-containing endosomes were prepared by differential centrifugation. The endosomes were incubated in various buffers, and hormone degradation was monitored by Sephadex G-50 chromatography and high-performance liquid chromatography (HPLC). Endosomes incubated in simple imidazole or HEPES (pH 7.4) buffers rapidly degraded insulin to intermediate- and then to low-molecular-weight products that were lost from the vesicles. HPLC analysis of insulin-sized material showed the products to be the same as those produced by intact cells. The endosomes did not acidify in these buffers (as assessed by the acridine orange method), and ATP had no effects. When the endosomes were incubated in a chloride-containing buffer, degradation was greatly inhibited, and acidification did not occur. Both insulin degradation and acidification were activated when Mg-ATP was added to this buffer system. HPLC analysis of the products generated in this system revealed not only typical cellular products but additional less hydrophobic products. Western-blot analysis of endosomal protein with anti-insulin-degrading enzyme antibody showed this enzyme to be present. In conclusion, isolated endosomes rapidly and completely degrade insulin through products that are typical of cellular degradation without requiring acidification. Chloride-containing buffers inhibit endosomal degradation, which is reversed by Mg-ATP, but this system does not mimic cellular degradation. At least one of the enzymes responsible for insulin degradation is insulin-degrading enzyme.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				S. Hambleton, S. P. Steinberg, M. D. Gershon, and A. A. Gershon Cholesterol Dependence of Varicella-Zoster Virion Entry into Target Cells J. Virol., July 15, 2007; 81(14): 7548 - 7558. [Abstract] [Full Text] [PDF]

				F. Authier, P. H. Cameron, C. Merlen, M. Kouach, and G. Briand Endosomal Proteolysis of Glucagon at Neutral pH Generates the Bioactive Degradation Product Miniglucagon-(19-29) Endocrinology, December 1, 2003; 144(12): 5353 - 5364. [Abstract] [Full Text] [PDF]

				B. Desbuquois, G. Chauvet, M. Kouach, and F. Authier Cell Itinerary and Metabolic Fate of Proinsulin in Rat Liver: In Vivo and in Vitro Studies Endocrinology, December 1, 2003; 144(12): 5308 - 5321. [Abstract] [Full Text] [PDF]

				F. Authier, M. Metioui, S. Fabrega, M. Kouach, and G. Briand Endosomal Proteolysis of Internalized Insulin at the C-terminal Region of the B Chain by Cathepsin D J. Biol. Chem., March 8, 2002; 277(11): 9437 - 9446. [Abstract] [Full Text] [PDF]

				F. Authier, G. M. Danielsen, M. Kouach, G. Briand, and G. Chauvet Identification of Insulin Domains Important for Binding to and Degradation by Endosomal Acidic Insulinase Endocrinology, January 1, 2001; 142(1): 276 - 289. [Abstract] [Full Text] [PDF]

				H. Fakhrai-Rad, A. Nikoshkov, A. Kamel, M. Fernstrom, J. R. Zierath, S. Norgren, H. Luthman, and J. Galli Insulin-degrading enzyme identified as a candidate diabetes susceptibility gene in GK rats Hum. Mol. Genet., September 1, 2000; 9(14): 2149 - 2158. [Abstract] [Full Text] [PDF]

				W. C. Duckworth, R. G. Bennett, and F. G. Hamel Insulin Degradation: Progress and Potential Endocr. Rev., October 1, 1998; 19(5): 608 - 624. [Abstract] [Full Text]

				F. G. Hamel, R. G. Bennett, and W. C. Duckworth Regulation of Multicatalytic Enzyme Activity by Insulin and the Insulin-Degrading Enzyme Endocrinology, October 1, 1998; 139(10): 4061 - 4066. [Abstract] [Full Text] [PDF]